Hospitalization rate before and after anti-TNF therapy, results from two referral centers
P Golovics, A Bálint, M Mandel, Z Végh, A Mohás, B Szilágyi, Á Szabó, Z Kürti, L Kiss, K Gecse, B Lovász, K Farkas, T Molnár, P Lakatos · Zeitschrift für Gastroenterologie · 2014 · Heft 05
Bibliografische Angaben
Zusammenfassung
Background and Aims: Hospitalization is an important outcome measure and a major driver of costs in patients with IBD. Our aim was to analyze prospectively the prevalence and predictors of hospitalization and re-hospitalization before and after anti-TNF therapy. Patients and Methods: Data of 194 consecutive IBD (152 CD, 42 UC) patients were analyzed (male/female: 88/106, median age at diagnosis: 24.0, IQR: 19 – 30 years, duration: 8, IQR: 8 – 12.5 years) in whom anti-TNF therapy was started after January 1, 2009. Total follow-up was 1874 patient-years and 474 patient-years with anti-TNF exposure. Both in- and ou…
